Microbiome in Neurological Conditions, Volume 180, the latest release in the International Review of Neurobiology series, highlights new advances in the field, with this volume presenting insightful chapters written by an international board of authors. Chapters in this volume explore the role of microbiome dysbiosis in neurological and psychiatric disorders, including its influence on neurochemical production in Parkinson’s Disease, immune system dysregulation in Huntington’s Disease, and alterations in the enteric neuromuscular system in Amyotrophic Lateral Sclerosis.
Other chapters examine the impact of microbial imbalances on psychiatric conditions such as schizophrenia, bipolar disorder, depression, and ADHD, along with the effects of perinatal antibiotic exposure and microbiome-based dietary supplements on brain health. This volume also delves into bacterial and viral infections linked to neuroinflammation and neuromuscular impairments, as well as maternal infections contributing to congenital neurological conditions. Offering a comprehensive perspective on the microbiome’s role in brain function and disease, this book provides valuable insights for researchers, clinicians, and those interested in the intersection of microbiology and neurology.
Provides the authority and expertise of leading contributors from an international board of authors
Presents the latest release in the International Review on Neurobiology series
Includes updated information on Microbiome in Neurological Conditions
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iv 6. Contributors - p. xvii 7. Preface - p. xxiii 8. Chapter One: Dysbiosis significantly elevates the probability of altered affective function in Alzheimer disease (AD) - p. 1 9. Chapter Two: Intestinal dysbiosis leads to the reduction in neurochemical production in Parkinson’s disease (PD) - p. 25 10. Chapter Three: Microbiota dysbiosis impact on the immune system dysregulation in Huntington’s disease (HD) - p. 57 11. Chapter Four: Altered microbiome influence on the enteric neuromuscular system in amyotrophic lateral sclerosis (ALS) - p. 95 12. Chapter Five: Oro-pharyngeal mucosal microbiome alternations causing immune system dysregulation in schizophrenia - p. 125 13. Chapter Six: Disruption in the human microbiome causing behavioural changes in bipolar disorder - p. 157 14. Chapter Seven: The role of microbiome in gut-brain-axis dysbiosis causing depression: From mechanisms to treatment - p. 189 15. Chapter Eight: The role of secondary genomes in neurodevelopment and co-evolutionary dynamics - p. 245 16. Chapter Nine: Abnormal microbiota due to prenatal antibiotic as a possible risk factor for Attention-Deficit / Hyperactivity Disorder (ADHD) - p. 299 17. Chapter Ten: Microbiome-based dietary supplements for better development and healthy brain - p. 329 18. Chapter Eleven: Bacterial meningitis is a significant catalyst for neuroinflammation - p. 369 19. Chapter Twelve: Viral agents in neuromuscular pathology - p. 397 20. Chapter Thirteen: Retrospective link of altered mental status and cryptococcal meningitis - p. 435 21. Chapter Fourteen: Acute disseminated encephalomyelitis - a monophonic illness - p. 473 22. Chapter Fifteen: Maternal exposure to rubella infection elevates risk of congenital rubella syndrome (CRS) - p. 501
Microbiome in Neurological Conditions, Volume 180, the latest release in the International Review of Neurobiology series, highlights new advances in the field, with this volume presenting insightful chapters written by an international board of authors. Chapters in this volume explore the role of microbiome dysbiosis in neurological and psychiatric disorders, including its influence on neurochemical production in Parkinson’s Disease, immune system dysregulation in Huntington’s Disease, and alterations in the enteric neuromuscular system in Amyotrophic Lateral Sclerosis.
Other chapters examine the impact of microbial imbalances on psychiatric conditions such as schizophrenia, bipolar disorder, depression, and ADHD, along with the effects of perinatal antibiotic exposure and microbiome-based dietary supplements on brain health. This volume also delves into bacterial and viral infections linked to neuroinflammation and neuromuscular impairments, as well as maternal infections contributing to congenital neurological conditions. Offering a comprehensive perspective on the microbiome’s role in brain function and disease, this book provides valuable insights for researchers, clinicians, and those interested in the intersection of microbiology and neurology.
Provides the authority and expertise of leading contributors from an international board of authors
Presents the latest release in the International Review on Neurobiology series
Includes updated information on Microbiome in Neurological Conditions
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iv 6. Contributors - p. xvii 7. Preface - p. xxiii 8. Chapter One: Dysbiosis significantly elevates the probability of altered affective function in Alzheimer disease (AD) - p. 1 9. Chapter Two: Intestinal dysbiosis leads to the reduction in neurochemical production in Parkinson’s disease (PD) - p. 25 10. Chapter Three: Microbiota dysbiosis impact on the immune system dysregulation in Huntington’s disease (HD) - p. 57 11. Chapter Four: Altered microbiome influence on the enteric neuromuscular system in amyotrophic lateral sclerosis (ALS) - p. 95 12. Chapter Five: Oro-pharyngeal mucosal microbiome alternations causing immune system dysregulation in schizophrenia - p. 125 13. Chapter Six: Disruption in the human microbiome causing behavioural changes in bipolar disorder - p. 157 14. Chapter Seven: The role of microbiome in gut-brain-axis dysbiosis causing depression: From mechanisms to treatment - p. 189 15. Chapter Eight: The role of secondary genomes in neurodevelopment and co-evolutionary dynamics - p. 245 16. Chapter Nine: Abnormal microbiota due to prenatal antibiotic as a possible risk factor for Attention-Deficit / Hyperactivity Disorder (ADHD) - p. 299 17. Chapter Ten: Microbiome-based dietary supplements for better development and healthy brain - p. 329 18. Chapter Eleven: Bacterial meningitis is a significant catalyst for neuroinflammation - p. 369 19. Chapter Twelve: Viral agents in neuromuscular pathology - p. 397 20. Chapter Thirteen: Retrospective link of altered mental status and cryptococcal meningitis - p. 435 21. Chapter Fourteen: Acute disseminated encephalomyelitis - a monophonic illness - p. 473 22. Chapter Fifteen: Maternal exposure to rubella infection elevates risk of congenital rubella syndrome (CRS) - p. 501
